Free Trial

AlphaQuest LLC Purchases 4,177 Shares of Kimberly-Clark Co. (NYSE:KMB)

Kimberly-Clark logo with Consumer Staples background
Remove Ads

AlphaQuest LLC grew its stake in Kimberly-Clark Co. (NYSE:KMB - Free Report) by 900.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,641 shares of the company's stock after buying an additional 4,177 shares during the period. AlphaQuest LLC's holdings in Kimberly-Clark were worth $608,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. OFI Invest Asset Management purchased a new position in Kimberly-Clark in the 4th quarter worth approximately $38,000. Atlantic Union Bankshares Corp grew its stake in Kimberly-Clark by 1.4% in the 4th quarter. Atlantic Union Bankshares Corp now owns 7,326 shares of the company's stock worth $960,000 after buying an additional 100 shares in the last quarter. Amundi grew its stake in Kimberly-Clark by 5.4% in the 4th quarter. Amundi now owns 2,401,501 shares of the company's stock worth $304,439,000 after buying an additional 122,312 shares in the last quarter. Dorsey & Whitney Trust CO LLC grew its stake in Kimberly-Clark by 10.9% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 2,545 shares of the company's stock worth $333,000 after buying an additional 251 shares in the last quarter. Finally, Lifeworks Advisors LLC grew its stake in Kimberly-Clark by 13.5% in the 4th quarter. Lifeworks Advisors LLC now owns 3,832 shares of the company's stock worth $502,000 after buying an additional 456 shares in the last quarter. Hedge funds and other institutional investors own 76.29% of the company's stock.

Kimberly-Clark Trading Down 2.3 %

Shares of KMB opened at $144.02 on Wednesday. The stock has a market capitalization of $47.77 billion, a P/E ratio of 19.08, a PEG ratio of 4.46 and a beta of 0.36. The company has a quick ratio of 0.54, a current ratio of 0.80 and a debt-to-equity ratio of 7.05. The firm has a fifty day simple moving average of $132.96 and a two-hundred day simple moving average of $136.48. Kimberly-Clark Co. has a twelve month low of $123.02 and a twelve month high of $150.45.

Remove Ads

Kimberly-Clark (NYSE:KMB - Get Free Report) last announced its quarterly earnings results on Tuesday, January 28th. The company reported $1.50 earnings per share for the quarter, meeting the consensus estimate of $1.50. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. On average, research analysts anticipate that Kimberly-Clark Co. will post 7.5 EPS for the current year.

Kimberly-Clark Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 2nd. Shareholders of record on Friday, March 7th will be issued a $1.26 dividend. The ex-dividend date is Friday, March 7th. This is a positive change from Kimberly-Clark's previous quarterly dividend of $1.22. This represents a $5.04 annualized dividend and a yield of 3.50%. Kimberly-Clark's dividend payout ratio is 66.75%.

Insiders Place Their Bets

In other Kimberly-Clark news, VP Andrew Drexler sold 10,838 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $141.00, for a total value of $1,528,158.00. Following the completion of the transaction, the vice president now directly owns 7,720 shares in the company, valued at approximately $1,088,520. This represents a 58.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.62% of the company's stock.

Analysts Set New Price Targets

A number of research firms have commented on KMB. Citigroup cut their price target on shares of Kimberly-Clark from $125.00 to $118.00 and set a "sell" rating for the company in a research note on Wednesday, January 15th. Wells Fargo & Company cut their price objective on shares of Kimberly-Clark from $140.00 to $130.00 and set an "equal weight" rating for the company in a research note on Tuesday, January 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $165.00 price objective on shares of Kimberly-Clark in a research note on Friday, January 24th. UBS Group upped their price objective on shares of Kimberly-Clark from $132.00 to $134.00 and gave the company a "neutral" rating in a research note on Wednesday, January 29th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $158.00 price objective (down previously from $161.00) on shares of Kimberly-Clark in a research note on Wednesday, January 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $143.64.

View Our Latest Stock Report on Kimberly-Clark

Kimberly-Clark Company Profile

(Free Report)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.

Featured Articles

Institutional Ownership by Quarter for Kimberly-Clark (NYSE:KMB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kimberly-Clark Right Now?

Before you consider Kimberly-Clark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.

While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Stocks to Benefit From Trump’s Tariffs in 2025

7 Stocks to Benefit From Trump’s Tariffs in 2025

While the impact of these tariffs remains uncertain, some stocks are positioned to thrive under these policies; check out these 7 stock picks now.

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads